| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 01/30/2007 | US7169412 Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells |
| 01/25/2007 | WO2006031607A3 A method of treating cancer |
| 01/25/2007 | WO2005118527A3 Fluorous capping reagents, and methods for peptide purification |
| 01/25/2007 | US20070021354 Viricides; immunomoderator; mixture with other Aids drugs |
| 01/25/2007 | US20070021350 Conjugates useful in the treatment of prostate cancer |
| 01/25/2007 | US20070021330 cyclic peptides used as enzyme inhibitors, optionally mixed with carriers or excipients, and viricides selected from interferons, ribavirin and amantadine, for treatment of viral diseases |
| 01/25/2007 | US20070020694 Linking oligopeptide to a stabilizing group, linking the oligopeptide to a therapeutic agent, testing if the conjugate is cleavable by Thimet oligopeptidase |
| 01/25/2007 | US20070020257 Which induce an antibody specific to cell surface protein antigen from Streptococcus; use in vaccine production and preventing dental caries |
| 01/25/2007 | US20070020176 Contrast agent |
| 01/25/2007 | CA2658491A1 Membrane-translocating peptides |
| 01/25/2007 | CA2612949A1 Cancer treatment using viruses, fluoropyrimidines and camptothecins |
| 01/24/2007 | EP1745071A2 Msh-agonist tripeptide conjugates |
| 01/24/2007 | EP1745064A2 Compounds for proteasome enzyme inhibition |
| 01/24/2007 | EP1565485B1 Perindopril |
| 01/24/2007 | EP1390405B1 Preparation of cholecystokinin agonists and antagonists and their therapeutic and diagnostic use |
| 01/24/2007 | CN1902225A Process for purifying interferon beta |
| 01/24/2007 | CN1902216A Depeptidized inhibitors of hepatitis c virus NS3 protease |
| 01/24/2007 | CN1902215A Inhibitors of methionine aminopeptidase-2 and uses thereof |
| 01/24/2007 | CN1296381C VEGF peptides and their use for inhibiting angiogenesis |
| 01/24/2007 | CN1296355C Method for synthesis of perindopril and its pharmaceutically acceptable salts |
| 01/23/2007 | US7166633 Method for synthesising perindopril and the pharmaceutically acceptable salt thereof |
| 01/23/2007 | US7166594 Streptogramin derivatives, their preparation and compositions containing them |
| 01/23/2007 | US7166590 Antiischemic agents; cardiovascular disorders |
| 01/23/2007 | US7166580 Such as N-(toluene-4-sulfonyl)-(2S-indolin-2-carbonyl)-L-phenylalanine; integrins, cd antigens (VLA-4); antiinflammatory agents |
| 01/23/2007 | US7166579 inhibitors of dipeptidyl peptidase; treatment of impaired glucose tolerance, glucosuria, hyperlipidaemia, metabolic acidoses, diabetes mellitus, diabetic neuropathy and nephropathy and of sequelae of diabetes mellitus in mammals |
| 01/23/2007 | US7166436 Compound for use as diagnostic tool in protein analysis |
| 01/18/2007 | WO2007007060A2 N- or c- terminally modified small peptides |
| 01/18/2007 | WO2007006548A2 Antibacterial amide macrocycles vii |
| 01/18/2007 | WO2006103274A9 Age inhibitors |
| 01/18/2007 | WO2006086098A3 Mass spectrometric methods and products |
| 01/18/2007 | WO2006072048A3 Compositions and methods for identifying modulators of hausp |
| 01/18/2007 | WO2005124341A8 Stable isotope labeled polypeptide standards for protein quantitation |
| 01/18/2007 | WO2005111058A9 Intracellular delivery of osteoinductive proteins and peptides |
| 01/18/2007 | US20070015716 Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs |
| 01/18/2007 | US20070014747 Novel peptidic conjugates for alopecia preventive and curative treatment |
| 01/18/2007 | DE102005032781A1 Antibakterielle Amid-Markozyklen VII Antibacterial amide Marko cycles VII |
| 01/18/2007 | DE102005032307A1 Oligomere freier Fettsäuren und diese enthaltende Arzneimittel Oligomers of free fatty acids and pharmaceutical compositions containing them |
| 01/17/2007 | EP1743883A1 Use of biphenyl-derived thiamides as calpain inhibitors |
| 01/17/2007 | EP1743034A2 Peptide substrates recognisable by a botulinum toxin a, bont/a and the use thereof |
| 01/17/2007 | EP1742914A1 Cyclobutenedione groups-containing compounds as inhibitors of hepatitis c virus ns3 serine protease |
| 01/17/2007 | EP1742913A1 Inhibitors of hepatitis c virus ns3/ns4a serine protease |
| 01/17/2007 | EP1453852B1 Selective urokinase inhibitors |
| 01/17/2007 | EP1341531B1 Lactam compound to inhibit beta-amyloid peptide release or synthesis |
| 01/17/2007 | EP1087996B1 Glycosulfopeptides and methods of synthesis and use thereof |
| 01/17/2007 | CN1898219A Novel keto-oxadiazole derivatives as cathepsin inhibitors |
| 01/16/2007 | US7164049 Process for the preparation of 3,3-dimethylbutanal |
| 01/16/2007 | US7163923 Peptide deformylase activated prodrugs |
| 01/16/2007 | US7163922 Tripeptide derivatives for the treatment of postlesional diseases of the nervous system |
| 01/16/2007 | US7163921 Peptide derivatives and medicinal compositions |
| 01/16/2007 | US7163918 Attachment to carrier peptide; increasing absorption of through intestinal epithelia; bioavailability, reliability, sustained release |
| 01/16/2007 | US7163917 Synthesis method of alanylglutamine |
| 01/16/2007 | US7163802 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 01/11/2007 | WO2007005300A2 Treatment of dry eye |
| 01/11/2007 | WO2007004876A2 Peptides inhibiting angiotensin-converting enzyme |
| 01/11/2007 | WO2006096829A3 Thyrotropin-releasing hormone analogs and method of use |
| 01/11/2007 | US20070010572 Reaction of benzyl (2S)-2,3,4,5,6,7-hexahydro-1H-indole-2-carboxylate with triethylamine and then (2S)-2-[(tert-butoxycarbonyl)amino]propionyl chloride and reaction of product with ethyl 2-oxopentanoate and hydrogenation using platinum on carbon catalyst |
| 01/11/2007 | US20070010453 Prodrugs of GABA analogs, compositions and uses thereof |
| 01/11/2007 | US20070010452 Methionine aminopeptidase-2 inhibitors and methods of use thereof |
| 01/11/2007 | US20070009440 Peptide Conjugates and Fluorescence Detection Methods for Intarcellular Caspase Assay |
| 01/11/2007 | CA2613749A1 Methods and compositions for diagnosis and treatment of viral and bacterial infections |
| 01/11/2007 | CA2613464A1 Treatment of dry eye |
| 01/11/2007 | CA2613112A1 Hcv inhibitors |
| 01/10/2007 | EP1741719A1 Epithelial cell growth promoter |
| 01/10/2007 | EP1741428A2 Cell adhesion inhibitors |
| 01/10/2007 | EP1740600A1 Intracellular delivery of osteoinductive proteins and peptides |
| 01/10/2007 | EP1740173A1 Azabicyclo-octane inhibitors of iap |
| 01/10/2007 | EP1073673B1 OCTAHYDRO-6,10-DIOXO-6H-PYRIDAZINO/1,2-a/ /1,2/DIAZEPIN-1-CARBOXYLIC ACID DERIVATIVES, PREPARATION METHOD AND USE FOR PREPARING THERAPEUTICALLY ACTIVE COMPOUNDS |
| 01/10/2007 | EP0782580B1 Parallel selex |
| 01/10/2007 | CN1894274A Macrocyclic inhibitors of hepatitis C virus NS3-serine protease |
| 01/10/2007 | CN1894273A Peptide inhibiting angiotensin converting enzyme |
| 01/10/2007 | CN1894238A Diamine derivatives |
| 01/10/2007 | CN1893967A Leukocyte internalized peptide-drug conjugates |
| 01/10/2007 | CN1294258C Method for separating antibiotic peptide and separated antibiotic peptide |
| 01/10/2007 | CN1294145C Crystal of methyl ester of alpha-L-asparaginyl-L-phenylalanine |
| 01/09/2007 | US7161033 E.g., 2S [[(N-methylamino)acetyl]amino]-N-[2R-hydroxy-3-[[(1,3-benzodioxol-5-yl)sulfonyl](2-methylpropyl)amino]-1S-(phenylmethyl)propyl]-3,3-dimethyl-butanamide; in particular as inhibitors of HIV protease |
| 01/09/2007 | US7160983 1((-4-oxo- N2-(12-methyl-1-oxotetradecyl) L-ornithine) 4-(4-(4- hydroxyphenyl)-L-threonine)-5-L-serine-echinocandin B, and other derivatives |
| 01/09/2007 | US7160981 Peptide antagonists of DP transcription factors |
| 01/09/2007 | US7160854 Binaphthyl peptidomimetics for treating vancomycin resistant Staphylococcus aureas infections |
| 01/09/2007 | CA2380084C A process for preparing 2-aminomethyl-4-cyano-thiazole |
| 01/04/2007 | WO2006019982A3 Pin1-modulating compounds and methods of use thereof |
| 01/04/2007 | WO2005069894A8 Conformationally constrained smac mimetics and the uses thereof |
| 01/04/2007 | US20070004904 G-csf conjugates |
| 01/04/2007 | US20070004646 Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 01/04/2007 | US20070004645 Aromatic amides as potentiators of bioefficacy of anti-infective drugs |
| 01/04/2007 | US20070004644 For oral administration; atherosclerosis; cardiovascular diseases |
| 01/04/2007 | US20070004643 ((1S)-1-((((1S)-1-benzyl-2,3-dioxo-3-(cyclopropylamino)propyl)amino)carbonyl)-3-methylbutyl)carbamic acid 5-methoxy-3-oxapentyl ester; ischemic disease, immunologic disease, multiple sclerosis, Alzheimer's disease, osteoporosis, diseases caused by brain tissue damage, cataract, glaucoma |
| 01/04/2007 | US20070004642 Oxadiazole derivatives and drugs containing these derivatives as the active ingredient |
| 01/04/2007 | US20070004638 form C dihydrates; useful as they act directly on the pituitary gland cells to release growth hormone; storage stability |
| 01/04/2007 | US20070004637 Alzheimer's disease; for promoting secretion of amyloid precursor protein-alpha (sAPP), neurodegenerative disease, neuropathy in cerebrovascular disease, head trauma, spinal damage, encephalitis sequela, or cerebral palsy, memory disorder |
| 01/04/2007 | US20070004636 Method of degrading transcriptional factors of saccharometabolism-associated gene, method for inhibiting the degradation, and agent for inhibiting degradation and degradation inhibitor |
| 01/04/2007 | CA2613193A1 Thrombospondin-1 derived peptides and treatment methods |
| 01/03/2007 | EP1739097A1 Hyaluronic acid/methotrexate compound |
| 01/03/2007 | EP1739082A1 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 01/03/2007 | EP1738762A1 Preventive/remedy for diabetic complications using oligopeptide |
| 01/03/2007 | EP1737881A2 Novel compounds as inhibitors of hepatitis c virus ns3 serine protease |
| 01/03/2007 | EP1737821A1 3,4-(cyclopentyl)-fused proline compounds as inhibitors of hepatitis c virus ns3 serine protease |
| 01/03/2007 | EP1737819A1 Amino acid and peptide conjugates of arylalkylic acids for cosmetic use |
| 01/03/2007 | EP1737483A2 Cell death modulation via antagonists of fasl and fas activation |
| 01/03/2007 | EP1737479A1 Therapeutic administration of the scrambled anti-angiogenic peptide c16y |
| 01/03/2007 | EP1625150B1 Tripeptides and derivatives thereof for cosmetic application in order to improve skin structure |